METTL14 and central nervous system cancer: IGF2BP3 downregulated the expression of both m6A-associated writers (METTL3, METTL14) and erasers (FTO, ALKBH5), with a specific focus on FTO due to its more pronounced effect in both U87MG and GL261 glioma cell lines (Fig. 3c).